Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.
Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.
Active, not recruiting · NCT05389267 · Registry updated 2024-02-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients. | eye disorder, glaucoma, ocular hypertension | Active, not recruiting | Phase 1 / Phase 2 | 2024-02-07 | NCT05389267 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Laboratoires Thea | 11 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dr EL-HARAZI | Glendale | United States | 1 |